Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2003-11-28 (22 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VILLABE (91100), Essonne
PHARMACIE VILLABE : revenue, balance sheet and financial ratios
PHARMACIE VILLABE is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VILLABE (91100),
this company of category PME
shows in 2022 a revenue of 7.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE VILLABE (SIREN 451061105)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
7 252 362 €
N/C
N/C
N/C
5 660 819 €
5 645 349 €
5 739 909 €
Net income
51 909 €
1 256 112 €
668 121 €
908 595 €
520 366 €
368 077 €
345 598 €
383 694 €
329 239 €
EBITDA
N/C
N/C
866 936 €
N/C
N/C
N/C
470 111 €
548 481 €
508 722 €
Net margin
N/C
N/C
9.2%
N/C
N/C
N/C
6.1%
6.8%
5.7%
Revenue and income statement
In 2024, PHARMACIE VILLABE generates positive net income of 52 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 329 k€ -> 52 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
51 909 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 577%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 13%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
577.198%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
12.922%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
58.716
45.209
34.253
23.337
18.374
11.833
4.435
12.126
577.198
Financial autonomy
55.803
63.428
67.864
70.683
75.676
80.67
86.886
40.949
12.922
Repayment capacity
5.03
3.892
3.323
None
None
None
0.353
None
None
Cash flow / Revenue
5.842%
6.7%
6.558%
None%
None%
None%
9.825%
None%
None%
Sector positioning
Debt ratio
577.22024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average+50 pts over 3 years
In 2024, the debt ratio of PHARMACIE VILLABE (577.20) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
12.92%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch-53 pts over 3 years
In 2024, the financial autonomy of PHARMACIE VILLABE (12.9%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
0.35 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of PHARMACIE VILLABE (0.35) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 219.06. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
219.058
Liquidity indicators evolution PHARMACIE VILLABE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
251.236
365.149
311.902
151.484
231.183
333.329
321.616
77.945
219.058
Interest coverage
5.659
4.582
5.076
None
None
None
0.867
None
None
Sector positioning
Liquidity ratio
219.062024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good-13 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE VILLABE (219.06) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.87x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of PHARMACIE VILLABE (0.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE VILLABE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
826 203 €
663 103 €
755 210 €
0 €
0 €
0 €
794 279 €
0 €
0 €
Inventory turnover (days)
48
43
45
0
0
0
37
0
0
Customer payment term (days)
4
4
4
0
0
0
3
0
0
Supplier payment term (days)
39
25
28
0
0
0
26
0
0
Positioning of PHARMACIE VILLABE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE VILLABE is estimated at
724 688 €
(range 504 661€ - 1 084 174€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
504k€724k€1084k€
724 688 €Range: 504 661€ - 1 084 174€
NAF 5 année 2024
Valuation method used
Net Income Multiple
51 909 €
×
14.0x
=724 688 €
Range: 504 661€ - 1 084 175€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE VILLABE with other companies in the same sector:
Frequently asked questions about PHARMACIE VILLABE
What is the revenue of PHARMACIE VILLABE ?
The revenue of PHARMACIE VILLABE in 2022 is 7.3 M€.
Is PHARMACIE VILLABE profitable?
Yes, PHARMACIE VILLABE generated a net profit of 52 k€ in 2024.
Where is the headquarters of PHARMACIE VILLABE ?
The headquarters of PHARMACIE VILLABE is located in VILLABE (91100), in the department Essonne.
Where to find the tax return of PHARMACIE VILLABE ?
The tax return of PHARMACIE VILLABE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE VILLABE operate?
PHARMACIE VILLABE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart